Global Custom Market Research Reports Provider Company

phone

4D Molecular Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 24
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene delivery vehicles (novel AAV vectors) to deliver genes to any tissue or organ in the body. 4D Molecular Therapeutics develops pipeline products which targets therapeutic areas such as retina, heart, liver, brain, skeletal muscle and lung. The company works in collaboration with other organizations such as Roche and uniQure to develop novel therapies. 4D Molecular Therapeutics is headquartered at Emeryville, California, the US.

4D Molecular Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
4D Molecular Therapeutics Raises USD3 Million in Venture Financing 10
4D Molecular Therapeutics Raises USD7 Million in Venture Financing 11
Partnerships 12
4D Molecular Therapeutics Enters into Agreement with Foundation Fighting Blindness 12
4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 13
Licensing Agreements 14
uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 14
Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 15
4D Molecular Therapeutics Enters into Licensing Agreement with Roche 16
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 17
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 18
4D Molecular Therapeutics Inc - Key Competitors 19
4D Molecular Therapeutics Inc - Key Employees 20
4D Molecular Therapeutics Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Clinical Trials 22
Sep 19, 2017: 4D Molecular Therapeutics Receives $3 Million Follow-On Funding from Cystic Fibrosis Foundation Therapeutics for Gene Therapy IND Candidate for Cystic Fibrosis 22
Other Significant Developments 23
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables

List of Tables
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
4D Molecular Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
4D Molecular Therapeutics Raises USD3 Million in Venture Financing 10
4D Molecular Therapeutics Raises USD7 Million in Venture Financing 11
4D Molecular Therapeutics Enters into Agreement with Foundation Fighting Blindness 12
4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 13
uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 14
Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 15
4D Molecular Therapeutics Enters into Licensing Agreement with Roche 16
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 17
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 18
4D Molecular Therapeutics Inc, Key Competitors 19
4D Molecular Therapeutics Inc, Key Employees 20

List Of Figures

List of Figures
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from

View Report

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandards product portfolio

View Report

Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports